Özet:

Goal: In this study, we shared our clinical experience of the diagnosis, treatment and tracking processes of patients who undergo the parotidectomy procedure due to head and neck skin cancer (BBCK). Methods: 30 patients with elective and therapeutic parotidectomy due to BBCK between January 2012 and January 2020 (20 men and 10 women; average. Age: 76±9.8 years; distribution, 50-90 years) was included in this retrospective study. Elective parotidectomy 11 (36.7%) was administered in patients and therapeutic parotidectomy 19 (63.3%) was administered in patients. Primary tumor histopathology was squamous cell carcinoma in 23 patients, basal cell carcinoma in five patients and malignant melanoma in two patients. The most common localizations of the primary tumor were, respectively, the auricula (n=9), the shake area (n=7) and the preauricular area (n=6). 25 percent of patients (83. 3) a disconnection was made. 12 patients (40%) were subjected to postoperative radiation therapy. The patient’s average tracking time was 40.3±30.9 (distribution, 6-99) months. Three-year survival was 90 percent (9/10) and five-year survival was 77.8 percent (7/9) while three-year survival was 46.2 percent (6/13) and five-year survival was 22.2 percent (2/9) in patients with therapeutic parotidectomy. The survival rates of elective parotidectomy patients were both three and five years higher than therapeutic parotidectomy patients (p<0.05). The result: in patients with head-to-course skin cancer, the survival is gradually reduced if regional metastasis occurs, primarily in the parotic gland. Therefore, we consider that elective parotidectomy should be applied to high-risk patients. When therapeutic parotidectomy is needed, the neck disection should be done and should be remembered that radiotherapy may be required according to the postoperative pathology report. Keywords: cancer, headache, metastasis, parotis, skin.

Anahtar Kelimeler: